Arcturus Therapeutics Holdings (ARCT) Stock Price & Financial Analysis
Arcturus Therapeutics Holdings Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Arcturus Therapeutics Holdings
What is the current stock price for ARCT?
As of the latest trading session, ARCT stock trades at $8.03. The 52-week range is $5.85–$24.17, with a day range of $7.52–$8.27.
What is the P/E ratio for ARCT?
The P/E ratio (Price-to-Earnings) for ARCT is shown in the Key Statistics section. This valuation metric helps compare Arcturus Therapeutics Holdings Inc. to industry peers.
Does ARCT pay dividends?
Arcturus Therapeutics Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARCT?
Based on 12 analysts, the consensus for ARCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ARCT?
Arcturus Therapeutics Holdings's market capitalization is $219.9M, classifying it as a micro-cap company. Arcturus Therapeutics Holdings operates in the Healthcare sector within the Biotechnology industry.